Price achieved for first indication vs. ASMR
CRA Life Sciences continues its series on leveraging RADAR, its orphan drug data repository, with a focus on PMA trends between ASMR outcomes and average annual
Industries
Life Sciences
We bring clarity to complex challenges.
For more than 25 years, life science companies, law firms, and regulatory agencies around the globe have turned to CRA’s life sciences consultants when they need clarity and solutions to the industry’s most complex issues. Clients value our deep industry knowledge, rigorous analytic techniques, and decades of hands-on experience spanning thousands of successful engagements.
Engagements
- 01Developing market-access focused segmentation and typing tool to aid uptake of bispecific oncology productsA leading pharmaceutical company sought support from CRA’s Life Sciences consultants in understanding how to best segment, target, and activate key accessView engagement
- 02Estimation of historical sales in a stateCRA was retained on behalf of defendants to address the estimation of historical retail sales for a product that is the subject of litigation under state law.View engagement
- 03Valuation of gene editing patentsCRA’s Life Sciences Practice was retained by a biotechnology company to perform a valuation of its gene editing patent portfolio, and to provide...View engagement
Contact a Life Sciences expert.
See all Life Sciences expertsUpcoming events
NELF 10th Annual John G.L. Cabot Award Dinner
CRA is a proud sponsor of the event supporting the not-for-profit public interest foundation whose mission is promoting public discourse on the proper role of...
World Orphan Drug Congress EU 2024
CRA is a proud sponsor of the conference. Come visit us at booth #41! Bhavesh Patel and Owen Male present the session titled “Maximizing Value & Positioning in...
Recent events
26th Annual Horizons for Homeless
CRA is a proud sponsor of the event honoring Pulitzer prize-winning journalist, Andrea Elliott, author of Invisible Child: Poverty, Survival, and Hope in an...
US Oncology in 2024 and Beyond: A Payer Perspective Webinar
This CRA-moderated 30-minute, intimate roundtable discussion focuses on several of the key ongoing and emerging topics in oncology and what this may mean for...